Autonomic hyperreflexia.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D006801:Humans; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D012021:Reflex, Abnormal / Q000188:drug therapy*; D013565:Sympatholytics / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D013565:Sympatholytics; D010643:Phenoxybenzamine; D010646:Phentolamine